Former LA AG Charles C. Foti launches investigation into Akero Therapeutics following Phase 2b trial failure and securities lawsuit.
Former Louisiana Attorney General Charles C. Foti, Jr. has launched an investigation through his law firm, Kahn Swick & Foti, LLC, into Akero Therapeutics, Inc. (NasdaqGS: AKRO). This follows the company's Phase 2b SYMMETRY trial failure and an ongoing securities class action lawsuit alleging undisclosed material information. KSF is assessing potential breaches of fiduciary duties by Akero's executives. Long-term shareholders are encouraged to contact KSF for assistance.
September 07, 2024
3 Articles